In patients with type 2 diabetes and recent MI, colchicine reduced a composite CV outcome at 23 mo.

Bates, Eric R · Ann Intern Med · 2024

Where this comes from

Abstract

Roubille F, Bouabdallaoui N, Kouz S, et al. <b>Low-dose colchicine in patients with type 2 diabetes and recent myocardial infarction in the COLchicine Cardiovascular Outcomes Trial (COLCOT).</b> Diabetes Care. 2024;47:467-470. 38181203.

Medical subject headings